Search

everythinglearnresearchcommunity

for

Search:↓

FPHL affects hair density and diameter, causing visible hair loss in older women.

Spironolactone helps regrow hair in women with hair loss.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Hair stiffness is higher when it has more para-like cortical cells.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

The document concludes that hair loss in women is treated with medications, therapies, and surgery in Western medicine, and with acupuncture and herbs in Chinese medicine, but hereditary hair loss is hard to reverse.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hair restoration surgery has evolved over time, with a focus on natural-looking results and managing patient expectations, while also considering potential complications and the lifelong progression of male pattern baldness.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.